Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial.

ABSTRACT:

SUBMITTER: Bosteels C 

PROVIDER: S-EPMC7273817 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature